Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
DLH Holdings Corp is a specialty business services business based in the US. DLH shares (DLHC) are listed on the NASDAQ and all prices are listed in US Dollars. DLH employs 2,300 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $14.95 |
|---|---|
| 52-week range | $10.21 - $21.49 |
| 50-day moving average | $15.88 |
| 200-day moving average | $16.11 |
| Wall St. target price | $21.00 |
| PE ratio | 10.0336 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.49 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.95 from 2022-07-01
| 1 week (2022-06-29) | -0.53% |
|---|---|
| 1 month (2022-06-06) | -12.47% |
| 3 months (2022-04-06) | -16.62% |
| 6 months (2022-01-06) | -25.03% |
| 1 year (2021-07-06) | 36.78% |
|---|---|
| 2 years (2020-07-06) | 99.33% |
| 3 years (2019-07-05) | 185.85% |
| 5 years (2017-07-06) | 160.91% |
Valuing DLH stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of DLH's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
DLH's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, DLH shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
DLH's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1263. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into DLH's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
DLH's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $39.4 million.
The EBITDA is a measure of a DLH's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $388.2 million |
|---|---|
| Operating margin TTM | 8.12% |
| Gross profit TTM | $51.5 million |
| Return on assets TTM | 10.32% |
| Return on equity TTM | 29.37% |
| Profit margin | 5.34% |
| Book value | $6.44 |
| Market capitalisation | $191.3 million |
TTM: trailing 12 months
We're not expecting DLH to pay a dividend over the next 12 months.
DLH's shares were split on a 1:4 basis on 20 April 2008. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DLH shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for DLH shares which in turn could have impacted DLH's share price.
Over the last 12 months, DLH's shares have ranged in value from as little as $10.21 up to $21.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DLH's is 1.3276. This would suggest that DLH's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.